Literature DB >> 26588169

A review of the use of fiducial markers for image-guided bladder radiotherapy.

Conor P Nolan1, Elizabeth J Forde1.   

Abstract

BACKGROUND: Enhancing target visualization and reducing set-up errors in image-guided radiotherapy (IGRT) are issues faced when trying to implement more conformal and partial bladder techniques. This review examines the evidence available pertaining to the clinical use of Lipiodol and gold fiducials for IGRT for bladder cancer.
MATERIAL AND METHODS: Nine published articles relating to the feasibility of using Lipiodol injections or gold fiducial markers in IGRT for bladder patients were recruited from a database search strategy. Set-up errors were evaluated in addition to the stability and visibility of each on verification imaging. Adverse reactions from the insertion of each method were also assessed.
RESULTS: Both Lipiodol and gold fiducials have the potential to remain stable and visible in the bladder, however, fading, washout and seed loss was also reported. Set-up errors can be reduced by using Lipiodol or fiducial registration when compared to other registration techniques. Adverse reactions reported were minimal for each.
CONCLUSION: Current evidence suggests that Lipiodol injections and gold fiducial markers present as promising and highly accurate methods of overcoming interfraction bladder motion in IGRT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26588169     DOI: 10.3109/0284186X.2015.1110250

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  Potential for BioXmark liquid fiducial marker to improve identification of superficial component of canine oral tumors for computer-based radiation therapy planning.

Authors:  Benoit Clerc-Renaud; Mary-Keara Boss; Lynn R Griffin; Susan M LaRue; Del Leary
Journal:  Can Vet J       Date:  2019-10       Impact factor: 1.008

2.  Exploratory models comparing ethiodized oil-glue and gold fiducials for bladder radiotherapy image-guidance.

Authors:  Daryl Lim Joon; Alexandra Berlangieri; Benjamin Harris; Mark Tacey; Rachel O'Meara; Brent Pitt; Angela Viotto; Kerryn Brown; Michal Schneider; Nathan Lawrentschuk; Shomik Sengupta; Colleen Berry; Trish Jenkins; Michael Chao; Morikatsu Wada; Farshad Foroudi; Vincent Khoo
Journal:  Phys Imaging Radiat Oncol       Date:  2021-02-06

3.  A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy.

Authors:  Matthew D Greer; Stephanie K Schaub; Stephen R Bowen; Jay J Liao; Kenneth Russell; Jonathan J Chen; Emily S Weg; Juergen Meyer; Tristan Alving; George R Schade; John L Gore; Sarah P Psutka; Robert B Montgomery; Michael Schweizer; Evan Y Yu; Petros Grivas; Jonathan L Wright; Jing Zeng
Journal:  Adv Radiat Oncol       Date:  2021-11-21

4.  BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial.

Authors:  Mischa de Ridder; Lara C Gerbrandy; Theo M de Reijke; Karel A Hinnen; Maarten C C M Hulshof
Journal:  Br J Radiol       Date:  2020-06-01       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.